Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

77.82
-0.6000-0.77%
Post-market: 77.820.00000.00%19:36 EDT
Volume:1.53M
Turnover:120.42M
Market Cap:5.80B
PE:-18.46
High:80.25
Open:77.69
Low:76.29
Close:78.42
52wk High:85.04
52wk Low:26.20
Shares:74.49M
Float Shares:57.56M
Volume Ratio:0.58
T/O Rate:2.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.2155
EPS(LYR):-4.2155
ROE:-31.57%
ROA:-21.11%
PB:6.41
PE(LYR):-18.46

Loading ...

OverviewCompanyNewsFilings

Apogee Therapeutics Up Over 21%, on Pace for Largest Percent Increase Since March 2024 -- Data Talk

Dow Jones
·
Mar 23

Apogee Therapeutics Price Target Maintained With a $137.00/Share by BTIG

Dow Jones
·
Mar 23

Top Midday Stories: Trump Orders 5-Day Postponement of Strikes on Iranian Energy Sites; JPMorgan Launches $8 Billion Junk-Bond Sale for EA Buyout

MT Newswires Live
·
Mar 23

Apogee Therapeutics, Tower Semiconductor, Norwegian Cruise Line And Other Big Stocks Moving Higher On Thursday

Benzinga_recent_news
·
Mar 23

Apogee Therapeutics Stock Rallies On Encouraging Eczema Drug Data Readout

Benzinga_recent_news
·
Mar 23

Apogee Therapeutics Inc : Jefferies Raises Target Price to $100 From $95

THOMSON REUTERS
·
Mar 23

Why Did Apogee Therapeutics Stock (APGE) Soar Today?

TIPRANKS
·
Mar 23

Apogee Therapeutics Shares Climb on Positive Mid-Stage Trial Results

Dow Jones
·
Mar 23

Apogee Therapeutics price target raised to $120 from $95 at Wedbush

TIPRANKS
·
Mar 23

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday

MT Newswires Live
·
Mar 23

BUZZ-U.S. STOCKS ON THE MOVE-Energy firms, Cencora, Stryker

Reuters
·
Mar 23

Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE) and Solid Biosciences (SLDB)

TIPRANKS
·
Mar 23

Apogee data further derisk zumilokibart path to approval, says Stifel

TIPRANKS
·
Mar 23

BUZZ-U.S. STOCKS ON THE MOVE-United Airlines, Synopsys, PG&E

Reuters
·
Mar 23

Wedbush Raises Price Target on Apogee Therapeutics to $120 From $95, Keeps Outperform Rating

MT Newswires Live
·
Mar 23

Top Premarket Gainers

MT Newswires Live
·
Mar 23

Apogee Shares up 16.6% Premarket After Co Says Eczema Drug Delivers Lasting Benefit in Mid-Stage Trial

THOMSON REUTERS
·
Mar 23

BUZZ-Apogee jumps as eczema drug delivers lasting benefit in mid-stage trial

Reuters
·
Mar 23

Apogee Therapeutics reports ‘positive’ results from Part A of Phase 2 APEX trial

TIPRANKS
·
Mar 23

Apogee Therapeutics Announces Positive Phase 2 Part a 52-Week Data of Zumilokibart (Apg777), Demonstrating Maintenance and Deepening of Responses With Every 3- and 6-Month Dosing in Moderate-to-Severe Atopic Dermatitis

THOMSON REUTERS
·
Mar 23
More